The successful implementation of infrastructure projects through public–private partnerships (PPPs) significantly relies on a well-designed procurement scheme; however, there is currently no established systematic decision-making model to identify the most optimal one. This paper explores the factors affecting the selection of public–private partnership schemes in infrastructure projects, with a particular focus on the differences between developed and emerging economies. The study opted for a comprehensive literature review and open-ended interviews to validate 25 critical factors affecting the optimum selection of PPP procurement for infrastructure projects. Then, a questionnaire survey was adopted to evaluate the selected factors and empirically examine the differences and commonalities between developed and emerging economies. The results highlighted the “financial attraction of projects to investors” and “financial viability based on the net present value and risk-adjusted present value” as the two most important factors. While the importance of most selection factors was agreed upon, nine selection factors were ranked unanimously higher for developed economies than for emerging economies. The findings of this study will aid in comprehending the factors that impact the choice of PPP schemes and provide insights for policymakers and project managers in both developed and emerging economies. These factors serve as inputs in developing a decision-making framework that aids both public and private stakeholders in selecting the most appropriate PPP procurement schemes for infrastructure projects.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.